Alivus Life Sciences Ltd (ALIVUS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1003513,
    "name": "Alivus Life",
    "stock_name": "Alivus Life",
    "full_name": "Alivus Life Sciences Ltd",
    "name_url": "stocks-analysis/alivus-life",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,059.30",
    "chg": 9.6,
    "chgp": "0.91%",
    "dir": 1,
    "prev_price": "1,049.70",
    "mcapval": "12,994.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543322,
    "symbol": "ALIVUS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE03Q201024",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "34.2 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/alivus-life-1003513-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Alivus Life Sciences Gains 4.97%: 4 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-gains-497-4-key-factors-driving-the-weeks-momentum-3983063",
        "imagepath": "",
        "date": "2026-05-09 12:00:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Technical momentum shifts signal bullish outlook</p>\n                    <p><strong>5 May:</strong> Mixed technical signals amid Mojo Grade downgrade</p>\n                    <p><strong>7 May:</strong> Mojo Grade upgraded to Buy following strong quarterly results</p>\n                    <p><strong>7 May:</strong> Bullish momentum confirmed with 4.54% daily gain</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,067.85</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,..."
      },
      {
        "title": "When is the next results date for Alivus Life Sciences Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-alivus-life-sciences-ltd-3982491",
        "imagepath": "",
        "date": "2026-05-08 23:17:21",
        "description": "The next results date for Alivus Life Sciences Ltd is scheduled for 14 May 2026...."
      },
      {
        "title": "Alivus Life Sciences Ltd Upgraded to Buy on Strong Technical and Financial Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-sciences-ltd-upgraded-to-buy-on-strong-technical-and-financial-performance-3979104",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlivusLifeScien_mojoScore_3979104.png",
        "date": "2026-05-07 08:32:53",
        "description": "Alivus Life Sciences Ltd has seen its investment rating upgraded from Hold to Buy, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, effective from 6 May 2026, follows a robust quarter and a bullish shift in market sentiment, positioning the small-cap pharmaceutical company favourably against its peers and broader market benchmarks."
      },
      {
        "title": "Alivus Life Sciences Ltd Sees Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-3967548",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AlivusLifeScien_technicaldot_3967548.png",
        "date": "2026-04-29 08:03:58",
        "description": "Alivus Life Sciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a nuanced market sentiment. Despite a recent downgrade from a Buy to a Hold rating by MarketsMOJO, the stock exhibits a blend of bullish and mildly bearish technical indicators, signalling a cautious outlook for investors navigating this evolving landscape."
      },
      {
        "title": "Alivus Life Sciences Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-sciences-ltd-is-rated-buy-3960623",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AlivusLifeScien_mojoScore_3960623.png",
        "date": "2026-04-24 10:10:31",
        "description": "Alivus Life Sciences Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 10 April 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 24 April 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "Alivus Life Sciences Gains 2.25%: Technical Upgrades and Strong Quarterly Results Drive Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-gains-225-technical-upgrades-and-strong-quarterly-results-drive-momentum-3952199",
        "imagepath": "",
        "date": "2026-04-18 11:03:42",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>13 Apr:</strong> Mojo Grade upgraded to Buy on strong technical and financial performance</p>\n                    <p><strong>13 Apr:</strong> Technical momentum shifts signal bullish outlook</p>\n                    <p><strong>17 Apr:</strong> Stock closes at Rs.1,066.65, down 0.61% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,043.20</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,066.65</div><div class=\"stat-change positive\">+2.25%</div></div>\n                    ..."
      },
      {
        "title": "Alivus Life Sciences Ltd Upgraded to Buy on Strong Technical and Financial Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-sciences-ltd-upgraded-to-buy-on-strong-technical-and-financial-performance-3944205",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AlivusLifeScien_mojoScore_3944205.png",
        "date": "2026-04-13 08:24:16",
        "description": "Alivus Life Sciences Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, effective from 10 April 2026, underscores the company’s robust quarterly results, bullish technical signals, and consistent long-term returns that have outpaced broader market benchmarks."
      },
      {
        "title": "Alivus Life Sciences Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-technical-momentum-shifts-signal-bullish-outlook-3944076",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AlivusLifeScien_technicaldot_3944076.png",
        "date": "2026-04-13 08:04:18",
        "description": "Alivus Life Sciences Ltd has recently experienced a notable shift in its technical momentum, upgrading from a mildly bullish to a bullish trend. Supported by positive signals from key indicators such as MACD, Bollinger Bands, and moving averages, the small-cap pharmaceutical company is demonstrating strength in price action and market sentiment, outperforming broader benchmarks over multiple timeframes."
      },
      {
        "title": "Alivus Life Sciences Gains 3.79%: 3 Key Technical Shifts Drive Weekly Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-gains-379-3-key-technical-shifts-drive-weekly-momentum-3942566",
        "imagepath": "",
        "date": "2026-04-11 11:03:45",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>6 Apr:</strong> Week opens at Rs.1,005.10</p>\n                    <p><strong>7 Apr:</strong> Technical momentum shifts amid mixed indicator signals</p>\n                    <p><strong>8 Apr:</strong> Technical momentum upgrades to mildly bullish with strong returns</p>\n                    <p><strong>10 Apr:</strong> Golden Cross formation signals potential bullish breakout</p>\n                    <p><strong>10 Apr:</strong> Week closes at Rs.1,043.20 (+3.79%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,005.10</div></div>\n                    <div cla..."
      }
    ],
    "total": 15,
    "sid": "1003513",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/alivus-life-sciences-1003513"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "10-Jun-2026",
      "details": "Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Analyst / Institutional Investor Meeting.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "04-Jun-2026",
      "details": "Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meeting",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "21-May-2026",
      "details": "Please find enclosed herewith transcript of Earnings Call held on 15th May 2026 which is also made available on the website of the Company.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alivus Life Sciences Ltd has declared <strong>250%</strong> dividend, ex-date: 01 Sep 25",
          "dt": "2025-09-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Alivus Life Sciences Gains 4.97%: 4 Key Factors Driving the Week’s Momentum

2026-05-09 12:00:04

Key Events This Week 4 May: Technical momentum shifts signal bullish outlook 5 May: Mixed technical signals amid Mojo Grade downgrade 7 May: Mojo Grade upgraded to Buy following strong quarterly results 7 May: Bullish momentum confirmed with 4.54% daily gain Week OpenRs.1,067.85 Week CloseRs.1,...

When is the next results date for Alivus Life Sciences Ltd?

2026-05-08 23:17:21

The next results date for Alivus Life Sciences Ltd is scheduled for 14 May 2026....

Alivus Life Sciences Ltd Upgraded to Buy on Strong Technical and Financial Performance

2026-05-07 08:32:53

Alivus Life Sciences Ltd has seen its investment rating upgraded from Hold to Buy, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, effective from 6 May 2026, follows a robust quarter and a bullish shift in market sentiment, positioning the small-cap pharmaceutical company favourably against its peers and broader market benchmarks.

Alivus Life Sciences Ltd Sees Technical Momentum Shift Amid Mixed Market Signals

2026-04-29 08:03:58

Alivus Life Sciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a nuanced market sentiment. Despite a recent downgrade from a Buy to a Hold rating by MarketsMOJO, the stock exhibits a blend of bullish and mildly bearish technical indicators, signalling a cautious outlook for investors navigating this evolving landscape.

Alivus Life Sciences Ltd is Rated Buy

2026-04-24 10:10:31

Alivus Life Sciences Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 10 April 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 24 April 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Alivus Life Sciences Gains 2.25%: Technical Upgrades and Strong Quarterly Results Drive Momentum

2026-04-18 11:03:42

Key Events This Week 13 Apr: Mojo Grade upgraded to Buy on strong technical and financial performance 13 Apr: Technical momentum shifts signal bullish outlook 17 Apr: Stock closes at Rs.1,066.65, down 0.61% on the day Week OpenRs.1,043.20 Week CloseRs.1,066.65+2.25% ...

Alivus Life Sciences Ltd Upgraded to Buy on Strong Technical and Financial Performance

2026-04-13 08:24:16

Alivus Life Sciences Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, effective from 10 April 2026, underscores the company’s robust quarterly results, bullish technical signals, and consistent long-term returns that have outpaced broader market benchmarks.

Alivus Life Sciences Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-04-13 08:04:18

Alivus Life Sciences Ltd has recently experienced a notable shift in its technical momentum, upgrading from a mildly bullish to a bullish trend. Supported by positive signals from key indicators such as MACD, Bollinger Bands, and moving averages, the small-cap pharmaceutical company is demonstrating strength in price action and market sentiment, outperforming broader benchmarks over multiple timeframes.

Alivus Life Sciences Gains 3.79%: 3 Key Technical Shifts Drive Weekly Momentum

2026-04-11 11:03:45

Key Events This Week 6 Apr: Week opens at Rs.1,005.10 7 Apr: Technical momentum shifts amid mixed indicator signals 8 Apr: Technical momentum upgrades to mildly bullish with strong returns 10 Apr: Golden Cross formation signals potential bullish breakout 10 Apr: Week closes at Rs.1,043.20 (+3.79%) Week OpenRs.1,005.10 <div cla...

View All News